等待开盘 01-30 09:30:00 美东时间
-0.100
-0.32%
今日重点评级关注:RBC Capital:维持Compass Pathways"跑赢大市"评级,目标价从16美元升至21美元;RBC Capital:维持GH Research"跑赢大市"评级,目标价从33美元升至40美元
01-26 14:32
Barrington Research analyst Alexander Paris maintains Interface (NASDAQ:TILE) with a Outperform and raises the price target from $32 to $36.
01-23 20:54
AlphaTON Claude Connector integrates Anthropic's Claude AI with TON blockchain via Telegram, enabling users to manage digital assets and execute transactions through natural language. It addresses cryptocurrency adoption barriers by simplifying complex blockchain operations within a familiar messaging app, while offering a visual interface and enterprise-grade security. Available now, the platform aims to make blockchain accessible to mainstream ...
01-21 16:12
Microchip Technology expanded its PolarFire FPGA smart embedded video ecosystem, offering solution stacks for reliable, low-power, high-bandwidth video connectivity. These stacks include hardware evaluation kits, development tools, IP cores, and reference designs, supporting applications like medical diagnostics, real-time camera connectivity, and more. The ecosystem features SDI Rx/Tx IP cores for SMPTE-compliant video transport and a quad CoaXP...
01-19 12:00
Interface ( ($TILE) ) has provided an update. Interface, Inc. entered into a Th...
2025-12-04 06:45
Companies Reporting Before The Bell • T. Rowe Price Group (NASDAQ:TROW) is esti...
2025-10-31 19:11
Interface (NASDAQ:TILE) raises FY2025 sales outlook from $1.370 billion-$1.390 billion to $1.375 billion-$1.390 billion vs $1.385 billion estimate.
2025-10-31 17:31
Interface (NASDAQ:TILE) reported quarterly earnings of $0.61 per share which beat the analyst consensus estimate of $0.48 by 27.08 percent. This is a 27.08 percent increase over earnings of $0.48 per share from the same
2025-10-31 17:30
今日重点评级关注:Roth Capital:维持Cingulate"买入"评级,目标价从10美元升至17美元;JMP证券:维持BioCryst Pharma"跑赢大市"评级,目标价从17美元升至27美元
2025-10-16 10:43
Barrington Research analyst Alexander Paris maintains Interface (NASDAQ:TILE) with a Outperform and maintains $32 price target.
2025-10-15 19:45